Clinical Trials Logo

Filter by:
NCT ID: NCT06110754 Recruiting - Sickle Cell Disease Clinical Trials

Development and Adaptation of I-STRONG for SCD

Start date: October 24, 2023
Phase: N/A
Study type: Interventional

This study develops and tests the feasibility and acceptability of an adapted intervention, Integrative Strong Body and Mind Training (I-STRONG), in adolescents with pain from sickle cell disease.

NCT ID: NCT06110689 Recruiting - Pectus Excavatum Clinical Trials

Capturing Physiologic Autonomic Data From Clinically Indicated Magnetic Resonance Imaging Scans in Children

CMRI
Start date: October 3, 2023
Phase:
Study type: Observational

The Fontan Procedure is a palliative surgical procedure used in pediatric patients with one functional ventricle. The procedure, a series of stepwise operations that alter cardiorespiratory physiology, separate the systemic and pulmonary circulations to create Fontan physiology, where the systemic venous blood flows passively and without ventricular thrust into the pulmonary circulation. The hallmark of the Fontan circulation is a sustained, abnormally elevated central venous pressure combined with decreased cardiac output, especially during periods of increased demands. Results of several studies in Fontan patients have shown reduced parasympathetic and sympathetic activity compared to controls. In children with congenital heart disease, a differential diagnosis of autonomic dysfunction may be part of their pathophysiology, a compensatory mechanism, a consequence of surgical procedures or a combination of these. In children, measurement of ANS function is equally important. Children with single ventricle physiology (and other cardiac conditions) have routine surveillance and cardiac magnetic resonance (CMR) imaging to monitor for disease progression. While autonomic data is routinely collected and is available from these scans, these data are rarely, collected and analyzed; however, our group has shown feasibility. Therefore, autonomic data is usually unavailable in children. Despite the availability of agerelated normal values, the predictive power of autonomic activity is understudied in children and there are no published studies of quantification of autonomic data in this population.

NCT ID: NCT06110598 Not yet recruiting - Pancreas Cancer Clinical Trials

CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)

Start date: June 1, 2024
Phase: Phase 2
Study type: Interventional

- This study is being done to find out if extending adjuvant chemotherapy for patients by giving additional chemotherapy can lengthen the amount of time before their cancer comes back. The additional chemotherapy is called capecitabine. - Capecitabine is an oral drug (taken by mouth). It is approved by the US Food and Drug Administration (FDA) for adjuvant treatment of adults with pancreatic cancer and also for the treatment of other types of cancer

NCT ID: NCT06110572 Recruiting - Clinical trials for Stage IV Lung Cancer

Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation

TESSERACT
Start date: April 24, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies the side effects, safety, and effectiveness of low dose radiation to the entire body (total body irradiation [TBI]) and higher dose radiation to known areas of cancer (hypofractionated radiation therapy [H-RT]) combined with atezolizumab and chemotherapy (carboplatin & etoposide) in treating patients with small cell lung cancer that has spread to disease sites outside of the lung (extensive stage). Extensive stage disease has historically been treated with chemotherapy alone with consideration of chest (thoracic) radiation therapy for those with response to chemotherapy, as well as consideration of preventative radiation therapy to the head (prophylactic cranial irradiation). Emerging evidence supports the synergistic interactions between immunotherapy and radiation therapy. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill tumor cells. Combining TBI and H-RT with atezolizumab and chemotherapy may improve response to treatment.

NCT ID: NCT06110546 Not yet recruiting - Clinical trials for Effect of Methadone on the Duration on Mechanical Ventilation

Impact of Methadone on Prolonged Mechanical Ventilation in Patients on Continuous Treatment With Opioids

IMPACTOR
Start date: November 15, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effect of methadone on the duration on mechanical ventilation in critically ill patients receiving more than 72 hours of mechanical ventilation (MV) by comparing the number of ventilator free days from enrollment to the time of discharge, to assess the safety of methadone administration in critically ill patients while in the hospital and to determine hospital length of stay from the time of enrollment to the time of discharge

NCT ID: NCT06110520 Recruiting - Myopia Clinical Trials

Violet Light for the Suppression of Myopia

Start date: June 7, 2023
Phase: N/A
Study type: Interventional

The study explores the suppression of myopia via violet light.

NCT ID: NCT06110494 Completed - Clinical trials for Apical Periodontitis

A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment

Start date: July 13, 2020
Phase: Phase 4
Study type: Interventional

The goal of this observational is study is to develop a protocol for root canal biofilms disinfection using a clinically approved and commercially available iron oxide nanoparticle formulation Ferumoxytol/H2O2 treatments. This protocol will be testing local single topical application of Ferumoxytol within the root canal system in patients going through routine root canal treatment, evaluate its potential as anti-biofilm treatment and compare it to the clinical gold standard disinfecting solution sodium hypochlorite (positive control) and saline (negative control).

NCT ID: NCT06110416 Recruiting - Clinical trials for Nausea, Postoperative

Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient

Start date: December 23, 2020
Phase: N/A
Study type: Interventional

From the research and current studies, post-operative nausea and vomiting is a common complaint after bariatric surgery. Nausea relief inhalers could improve post-operative nausea and vomiting without the need for further medications, subsequently reducing the chance of side effects. This study could help improve patient satisfaction and increase the ability of the patient to ambulate after surgery with the use of a nausea relief inhaler.

NCT ID: NCT06110364 Not yet recruiting - Clinical trials for Premature Ventricular Contraction

Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions

Start date: October 2023
Phase: Phase 3
Study type: Interventional

Prospective randomized control pilot study

NCT ID: NCT06110351 Recruiting - Clinical trials for Acute Myocardial Infarction

Acute Clinical Outcomes of Hemorrhagic Myocardial Infarction

MIRON-ACUTE
Start date: November 8, 2023
Phase:
Study type: Observational

Acute clinical outcomes 1. Mortality 2. Arrhythmia 3. Readmission 4. CVA 5. ADHF